{"id":5013,"date":"2025-10-21T09:15:21","date_gmt":"2025-10-21T02:15:21","guid":{"rendered":"https:\/\/c-techlabs.com\/intl\/?p=5013"},"modified":"2026-03-31T17:01:04","modified_gmt":"2026-03-31T10:01:04","slug":"ecct-physical-therapy-for-cancer-clinical-report","status":"publish","type":"post","link":"https:\/\/c-techlabs.com\/intl\/ecct-physical-therapy-for-cancer-clinical-report\/","title":{"rendered":"ECCT: Physical Therapy for Cancer &#8211; clinical report"},"content":{"rendered":"<p class=\"font_8 wixui-rich-text__text\"><span class=\"wixui-rich-text__text\">\u56fd\u969b\u6297\u8001\u5316\u518d\u751f\u533b\u7642\u5b66\u4f1a\u96d1\u8a8c \u7b2c 6 \u5dfb\uff0820\u221233\uff092024<br class=\"wixui-rich-text__text\" \/>By Shinichiro Akiyama, MD, PhD, FACP<br class=\"wixui-rich-text__text\" \/>Cancer gene; Immunotherapy Expert<br class=\"wixui-rich-text__text\" \/>Clinical Oncology, McGill University, CANADA<br class=\"wixui-rich-text__text\" \/>Faculty of Science and Technology, Keio University, JAPAN<br class=\"wixui-rich-text__text\" \/><br class=\"wixui-rich-text__text\" \/><strong>Mechanism of Action<\/strong><\/span><\/p>\n<p class=\"font_8 wixui-rich-text__text\"><span class=\"wixui-rich-text__text\">Electro Capacitive Cancer Therapy (ECCT) employs low-voltage, medium-frequency electric fields to disrupt mitotic progression by inducing microtubule depolymerization, ultimately triggering apoptosis in cancer cells while sparing normal tissues. By interfering with the electrostatic forces that stabilize spindle formation during cell division, ECCT selectively targets proliferating malignant cells without the systemic toxicity associated with conventional therapies such as chemotherapy and radiotherapy.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p class=\"font_8 wixui-rich-text__text\"><span class=\"wixui-rich-text__text\"><strong>Preclinical Evidence<\/strong><\/span><\/p>\n<p class=\"font_8 wixui-rich-text__text\"><span class=\"wixui-rich-text__text\">In vitro and in vivo studies have demonstrated ECCT\u2019s efficacy in suppressing tumor growth, with research indicating a 28\u201339% reduction in cancer cell proliferation and significant tumor shrinkage in murine models. Further investigations have revealed ECCT-mediated downregulation of IL-18 and CCL-2, key inflammatory cytokines implicated in tumor progression, as well as p53-independent p21 pathway activation leading to apoptosis in osteosarcoma cells. These findings highlight ECCT\u2019s potential as a targeted, non-cytotoxic oncologic intervention.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p class=\"font_8 wixui-rich-text__text\"><span class=\"wixui-rich-text__text\"><strong>Clinical Evidence<\/strong><\/span><\/p>\n<p class=\"font_8 wixui-rich-text__text\"><span class=\"wixui-rich-text__text\">ECCT has shown promising outcomes in multiple malignancies, including glioblastoma multiforme (GBM), breast cancer, lung cancer, and lymphoma, as evidenced by a retrospective analysis of 5,195 patients. A Kaplan-Meier survival analysis in GBM patients revealed a median overall survival (OS) of 28.9 months for ECCT-treated individuals versus 15.6 months for those receiving Temozolomide (TMZ) alone, suggesting superior efficacy with ECCT. Furthermore, ECCT\u2019s safety profile was highly favorable, with no high-grade systemic toxicity reported and only mild, localized discomfort in select cases.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p class=\"font_8 wixui-rich-text__text\"><span class=\"wixui-rich-text__text\"><strong>Tumor Response Classification<\/strong><\/span><\/p>\n<p class=\"font_8 wixui-rich-text__text\"><span class=\"wixui-rich-text__text\">Electrical Capacitance Volume Tomography (ECVT) has enabled the stratification of tumor responses into five categories, with soft, medium-to-high-grade tumors exhibiting the most favorable responses to ECCT, while highly aggressive phenotypes necessitate extended monitoring due to rapid metastatic potential. These findings suggest that ECCT may be\u00a0particularly effective in certain tumor subtypes, warranting further investigation into<br class=\"wixui-rich-text__text\" \/>patient selection criteria.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p class=\"font_8 wixui-rich-text__text\"><span class=\"wixui-rich-text__text\"><strong>Future Directions<\/strong><\/span><\/p>\n<p class=\"font_8 wixui-rich-text__text\"><span class=\"wixui-rich-text__text\">As a non-invasive, well-tolerated therapeutic modality, ECCT holds significant potential for patients with advanced, refractory, or chemotherapy-intolerant malignancies. Future research will focus on optimizing treatment parameters, investigating synergies with immune checkpoint inhibitors, and conducting large-scale, randomized clinical trials to establish ECCT as a paradigm-shifting oncologic intervention with broad clinical applicability.<br class=\"wixui-rich-text__text\" \/>If validated through further studies, ECCT could redefine the landscape of cancer treatment by offering a novel, mechanistically distinct alternative to conventional cytotoxic therapies.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u56fd\u969b\u6297\u8001\u5316\u518d\u751f\u533b\u7642\u5b66\u4f1a\u96d1\u8a8c \u7b2c 6 \u5dfb\uff0820\u221233\uff092024By Shinichiro Akiyama, MD, PhD, FACPCancer gene; Immunotherapy ExpertClinical Oncology, McGill University, CANADAFaculty of Science and Technology, Keio University, JAPANMechanism of Action Electro Capacitive Cancer Therapy (ECCT) employs low-voltage, medium-frequency electric fields to disrupt mitotic progression by inducing microtubule depolymerization, ultimately triggering apoptosis in cancer cells while sparing normal tissues. By interfering [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"advanced_seo_description":"","jetpack_seo_html_title":"","jetpack_seo_noindex":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[203,31],"tags":[],"class_list":["post-5013","post","type-post","status-publish","format-standard","hentry","category-clinical","category-research-articles"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/posts\/5013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/comments?post=5013"}],"version-history":[{"count":6,"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/posts\/5013\/revisions"}],"predecessor-version":[{"id":5023,"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/posts\/5013\/revisions\/5023"}],"wp:attachment":[{"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/media?parent=5013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/categories?post=5013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/c-techlabs.com\/intl\/wp-json\/wp\/v2\/tags?post=5013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}